Home Cart 0 Sign in  
X

[ CAS No. 65719-09-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 65719-09-7
Chemical Structure| 65719-09-7
Chemical Structure| 65719-09-7
Structure of 65719-09-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 65719-09-7 ]

Related Doc. of [ 65719-09-7 ]

Alternatived Products of [ 65719-09-7 ]

Product Details of [ 65719-09-7 ]

CAS No. :65719-09-7 MDL No. :MFCD00051961
Formula : C8H9NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :KLHWBYHFWALOIJ-UHFFFAOYSA-N
M.W : 151.16 Pubchem ID :7015327
Synonyms :

Calculated chemistry of [ 65719-09-7 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.25
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 40.48
TPSA : 39.19 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.43 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.84
Log Po/w (XLOGP3) : 1.11
Log Po/w (WLOGP) : 1.18
Log Po/w (MLOGP) : 0.66
Log Po/w (SILICOS-IT) : 1.64
Consensus Log Po/w : 1.29

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.75
Solubility : 2.7 mg/ml ; 0.0179 mol/l
Class : Very soluble
Log S (Ali) : -1.53
Solubility : 4.5 mg/ml ; 0.0298 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.47
Solubility : 0.512 mg/ml ; 0.00339 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.37

Safety of [ 65719-09-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 65719-09-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 65719-09-7 ]
  • Downstream synthetic route of [ 65719-09-7 ]

[ 65719-09-7 ] Synthesis Path-Upstream   1~16

  • 1
  • [ 65719-09-7 ]
  • [ 60032-57-7 ]
Reference: [1] Patent: WO2013/19621, 2013, A1,
  • 2
  • [ 917-54-4 ]
  • [ 65719-09-7 ]
  • [ 1721-12-6 ]
Reference: [1] Organic and Biomolecular Chemistry, 2012, vol. 10, # 30, p. 5924 - 5931
  • 3
  • [ 65719-09-7 ]
  • [ 56826-61-0 ]
YieldReaction ConditionsOperation in experiment
100%
Stage #1: With lithium aluminium tetrahydride In diethyl ether at 55℃; for 1.5 h; Heating / reflux
Stage #2: With water In diethyl ether at 0℃; for 1 h;
Example 6
Diethyl α-(4-hydroxy-3-methoxy-5-methylphenyl)-β-(3-(2-methylpyridyl))ethyl phosphonate
A solution of methyl 2-methylnicotinate (35.2 g, 234 mmol) in 275 ml dry ether was added dropwise to a vigorously stirred suspension of LiAlH4 (13.3 g, 350 mmol) in 600 ml dry ether.
The reaction mixture was heated to reflux with the oil bath of 55° for 1.5 h and was then cooled to 0°. H2O (64 ml) was added dropwise and, 1 h later, the upper layer was decanted off.
The remaining suspension was extracted with ether.
The combined organic phases were dried with MgSO4 and evaporated to yield 29.9 g (234 mmol, 100percent) of 3-(hydroxymethyl)-2-methylpyridine as an orange oil; GC-analysis indicated a purity of 100percent.
76%
Stage #1: With diisobutylaluminium hydride In hexane; dichloromethane at -78℃; for 4 h;
Stage #2: With water; rochelle salt In hexane; dichloromethane at 0℃;
To a solution of methyl 2-methylnicotinate (5.9 g, 39 mmol) in DCM (100 mL) under argon at -78 0C was added diisobutylaluminium hydride (IM in hexane, 97 mL, 97 mmol). The reaction mixture was stirred for 4 hours and then added to a saturated aqueous solution of Rochelle salt (200 mL) at 0 0C. The mixture was stirred until two layers had formed. The phases were separated and the aqueous phase was extracted with DCM (2 x 150 mL). The combined organic phases were dried (MgSO4) and concentrated in vacuo to give (2- methyl-pyridin-3-yl)-methanol (3.64 g, 76percent) as a yellow oil. Analytical LCMS: (System A, RT = 0.44 min), ES+: 123.9 [MH]+.
Reference: [1] Patent: US2002/49316, 2002, A1,
[2] Patent: US2005/124586, 2005, A1, . Location in patent: Page/Page column 9-10
[3] Patent: WO2009/147211, 2009, A1, . Location in patent: Page/Page column 25
[4] Patent: WO2009/42694, 2009, A1, . Location in patent: Page/Page column 75
[5] Patent: US2004/6114, 2004, A1, . Location in patent: Page 71
[6] Patent: EP1422228, 2004, A1, . Location in patent: Page 206
[7] Patent: US2005/131017, 2005, A1, . Location in patent: Page/Page column 105
[8] Patent: WO2013/19621, 2013, A1, . Location in patent: Page/Page column 38
  • 4
  • [ 65719-09-7 ]
  • [ 3222-56-8 ]
Reference: [1] Patent: US2002/49316, 2002, A1,
[2] Patent: WO2008/62182, 2008, A1,
  • 5
  • [ 65719-09-7 ]
  • [ 58539-65-4 ]
Reference: [1] Canadian Journal of Chemistry, 1995, vol. 73, # 4, p. 531 - 538
[2] Journal of Heterocyclic Chemistry, 2006, vol. 43, # 5, p. 1311 - 1317
  • 6
  • [ 79-37-8 ]
  • [ 65719-09-7 ]
  • [ 23616-31-1 ]
Reference: [1] Patent: US5391554, 1995, A,
  • 7
  • [ 65719-09-7 ]
  • [ 23616-31-1 ]
Reference: [1] Journal of Heterocyclic Chemistry, 2006, vol. 43, # 5, p. 1311 - 1317
  • 8
  • [ 67-56-1 ]
  • [ 201230-82-2 ]
  • [ 38749-79-0 ]
  • [ 65719-09-7 ]
YieldReaction ConditionsOperation in experiment
93.6% at 80℃; for 16 h; A mixture of 3-bromo-2-methylpyridine (5.0 g, 29.0 mmol), Pd(dppf)C12 (2.1 g, 2.9 mmol) and Et3N (8.8 g, 87 mmol) in MeOH (250 mL) was stirred at 80 °C and 5OPsi under CO for 1 6h. Solid was then filtered out and the filtrate was concentrated. The residue was purified by column chromatography (PE:EA=5: 1) to give the desired product (4.1 g, 93.6percent). ‘H NMR (CD3OD, 400MHz) (ppm): 8.57 - 8.42 (m, 1H), 8.08 (d, 1=8.0 Hz, 1H),7.10 (dd, 1=4.8, 7.8 Hz, 1H), 3.81 (s, 3H), 2.73 (s, 3H). LCMS (mlz): 152.0 [M+H]+
Reference: [1] Patent: WO2015/200677, 2015, A2, . Location in patent: Paragraph 00787; 00788
  • 9
  • [ 67-56-1 ]
  • [ 3222-56-8 ]
  • [ 65719-09-7 ]
YieldReaction ConditionsOperation in experiment
84% Reflux General procedure: To a solution of carboxylic acid 22 or 29–31 (0.1mol) in dry methanol (150mL), concd H2SO4 (20mL) was added. The mixture was refluxed for 15–20h (LC–MS control). The solvent was removed in vacuo, and the residue was dissolved in H2O. The solution was made alkaline with cold saturated aq K2CO3 and extracted with CH2Cl2 (4×50mL). The combined organic extracts were dried over Na2SO4 and evaporated in vacuo. The residue was purified by flash chromatography (EtOAc as eluent) or distilled in vacuo to give 17–20.
Reference: [1] Tetrahedron, 2013, vol. 69, # 33, p. 6799 - 6803
[2] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 7, p. 1913 - 1919
  • 10
  • [ 80171-29-5 ]
  • [ 107-02-8 ]
  • [ 65719-09-7 ]
Reference: [1] Organic Letters, 2016, vol. 18, # 21, p. 5640 - 5643
  • 11
  • [ 105-45-3 ]
  • [ 107-02-8 ]
  • [ 65719-09-7 ]
Reference: [1] Chemical Communications, 2008, # 35, p. 4207 - 4209
[2] European Journal of Organic Chemistry, 2013, # 19, p. 4131 - 4145
  • 12
  • [ 107-02-8 ]
  • [ 14205-39-1 ]
  • [ 65719-09-7 ]
Reference: [1] Chemical Communications, 2017, vol. 53, # 15, p. 2390 - 2393
[2] Journal of Heterocyclic Chemistry, 1991, vol. 28, # 5, p. 1315 - 1324
  • 13
  • [ 67-56-1 ]
  • [ 169229-06-5 ]
  • [ 65719-09-7 ]
Reference: [1] Tetrahedron Letters, 1995, vol. 36, # 28, p. 5065 - 5068
  • 14
  • [ 65719-09-7 ]
  • [ 116986-08-4 ]
YieldReaction ConditionsOperation in experiment
80.6% With N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile) In tetrachloromethane at 90℃; for 16 h; Inert atmosphere A mixture of methyl 2-methylnicotinate (4.1 g, 27.1 mmol), NBS (5.8 g, 32.5 mmol), AIBN (100 mg, 0.61 mmol) in carbon tetrachloride (55 mL) was stirred at 90 °C for 16 h under nitrogen. Once cooled, the reaction mixture was diluted with water (25 mL) and the aqueous layer was extracted with dichloromethane (50 mL x 3). The combined organic layers were concentrated in vacuo, and the resulting residue was purified by flash chromatography on Si02 to give the desired product (5.0 g, 80.6percent). LCMS (mlz): 229.9 (M+ 1).
Reference: [1] Patent: WO2015/200677, 2015, A2, . Location in patent: Paragraph 00522; 00523
[2] Tetrahedron Letters, 1981, vol. 22, # 50, p. 5097 - 5100
[3] Journal fuer Praktische Chemie (Leipzig), 1987, vol. 329, # 4, p. 557 - 562
[4] Patent: WO2012/61169, 2012, A1, . Location in patent: Page/Page column 49
  • 15
  • [ 65719-09-7 ]
  • [ 80957-68-2 ]
Reference: [1] Patent: WO2015/200677, 2015, A2,
  • 16
  • [ 65719-09-7 ]
  • [ 155058-02-9 ]
Reference: [1] Patent: WO2015/200677, 2015, A2,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 65719-09-7 ]

Esters

Chemical Structure| 125104-34-9

[ 125104-34-9 ]

Methyl 2-formylisonicotinate

Similarity: 0.93

Chemical Structure| 151509-01-2

[ 151509-01-2 ]

Methyl 2-(aminomethyl)nicotinate hydrochloride

Similarity: 0.91

Chemical Structure| 75358-89-3

[ 75358-89-3 ]

Methyl 2-cyanonicotinate

Similarity: 0.91

Chemical Structure| 37669-78-6

[ 37669-78-6 ]

Ethyl 2,4-dimethylnicotinate

Similarity: 0.91

Chemical Structure| 58481-17-7

[ 58481-17-7 ]

Methyl 2-(hydroxymethyl)isonicotinate

Similarity: 0.90

Related Parent Nucleus of
[ 65719-09-7 ]

Pyridines

Chemical Structure| 125104-34-9

[ 125104-34-9 ]

Methyl 2-formylisonicotinate

Similarity: 0.93

Chemical Structure| 3222-56-8

[ 3222-56-8 ]

2-Methylnicotinic acid

Similarity: 0.93

Chemical Structure| 151509-01-2

[ 151509-01-2 ]

Methyl 2-(aminomethyl)nicotinate hydrochloride

Similarity: 0.91

Chemical Structure| 75358-89-3

[ 75358-89-3 ]

Methyl 2-cyanonicotinate

Similarity: 0.91

Chemical Structure| 37669-78-6

[ 37669-78-6 ]

Ethyl 2,4-dimethylnicotinate

Similarity: 0.91